31
Participants
Start Date
August 5, 2014
Primary Completion Date
June 12, 2017
Study Completion Date
September 15, 2017
ASLAN001
ASLAN001 400mg BID daily; ASLAN001 500mg BID daily; or ASLAN001 300mg BID daily
cisplatin + capecitabine
Cisplatin 80 mg/m2 IV infusion and capecitabine 1,000 mg/m2 orally BID for 14 days every 3 weeks
cisplatin + 5-fluorouracil (or+ Leucovorin)
"Cisplatin 80 mg/m2 IV infusion and 5-fluorouracil 800 mg/m2/day IV infusion for 5 days every 3 weeks;~Or~Cisplatin 35 mg/m2 24-hour infusion for day 1 and day 8, 5-fluorouracil 2,000 mg/m2 and Leucovorin 300mg/m2 24-hour infusion for day 1, day 8 and day 15 every 4 weeks."
National Taiwan University Hospital, Taipei
Taipei Veterans General Hospital, Taipei
Queen Mary Hospital, Hong Kong
Lead Sponsor
ASLAN Pharmaceuticals
OTHER